Ropinirole

🧮 Dose calculator

Parkinson's disease · Regimen source: FDA Ropinirole · 2.2, Table 1

• • Weeks 1–4: 0.25, 0.5, 0.75, 1 mg three times daily; then weekly up to 9 and later max 24 mg/day. Taper over 7 days. FDA Ropinirole · 2.2, Table 1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Ropinirole · 8.1

  “Risk Summary There are no adequate data on the developmental risk associated with the use of ropinirole tablets in pregnant women.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Ropinirole · 8.2

  “Risk Summary There are no data on the presence of ropinirole in human milk, the effects of ropinirole on the breastfed infant, or the effects of ropinirole on milk production.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Ropinirole · 8.4

  “Safety and effectiveness in pediatric patients have not been established.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Ropinirole · 8.5

  “Pharmacokinetic trials conducted in patients demonstrated that oral clearance of ropinirole is reduced by 15% in patients older than 65 years compared with younger patients [see Clinical Pharmacology (12.3)] .”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.